Back
Delegates Premium Access

Cardiovascular toxicities reported with Poly ADP Ribose Polymerase (PARP) inhibitors in the FDA Adverse Event Reporting System

Session: Innovations and new insights in cardio oncology
Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer
Speaker: Doctor A. Boccia (University Of Bologna - Bologna, IT)
Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Angela Boccia

University Of Bologna - Bologna (Italy)
0 follower

5 more presentations in this session

Reducing administrative burden in cardio-oncology: an LLM-powered approach for automated summarization of oncology and cardiotoxicity histories in dutch medical records

Speaker: Doctor J. Heemelaar (Leiden, NL)

Access
Abstract
Like
Thumbnail

Characteristics of patients with nonbacterial thrombotic endocarditis and factors associated with occurrence of embolic events and prognosis

Speaker: Assistant Professor S. Gwak (Seoul, KR)

Access
Abstract
Slides
Like
Thumbnail

Acute myeloid leukemia with KMT2A rearrangements in children with congenital heart disease: case series and literature review

Speaker: Doctor G. Wu (Taoyuan, TW)

Access
Abstract
Slides
Like
Thumbnail

Does the short-term cardioprotection prevent diastolic dysfunction?

Speaker: Doctor M. Del Bene (Florence, IT)

Access
Abstract
Slides
Like
Thumbnail

Dosimetric evaluation of cardiac substructures in DIBH-VMAT and FB- VMAT in hypofractionated radiotherapy for left-sided breast cancer: a comparative planning study

Speaker: Doctor S. Rana (Gurugram, IN)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Innovations and new insights in cardio oncology

Speakers: Doctor A. Boccia, Doctor J. Heemelaar, Assistant Professor S. Gwak, Doctor G. Wu, Doctor M. Del Bene...
Access
Like
Thumbnail

About the event

Image

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources